Replies to post #591186 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Over 5 years from the end of 2017 to end of 2022, shares oustanding increased from 329 million to 1.067 billion.

1. You absolutely in no way shape or form can compare the time when NWBO was building the production facility for DCVAXL and maintaining a trial to the cost of the present day.

Second Im 75% convinced that NWBO will disappear (as in will be bought) between now and 9 months max 1 year

Third if not bought then after approval the SP will be much higher thus less dilution

4th I dont see NWBO management exercising any options or warrants ever but being bought off on the day NWBO is acquired. So technically we will never see those warrants and options translated into O/S

5Th you dont know what the number of C prefs are.

6th was it 477 million shares for management and staff? I thought it was 250 million?

[Poor Man -]

Just based in those numbers alone, the company has 1.54 billion equal to shares outstanding plus obligations under various derivatives. The full 1.7 billion in authorized shares is certainly going to be issued.

[dstock07734]

You've been here long enough to understand that NWBO is now at different development stage. The so-called dilution is actually like pumping fuel into the booster of the rocket before lift-off. Nothing can stop the lift-off!